Table 3 |
|||
|
T cell activation marker profile and Treg status in RA versus healthy control patients. |
|||
|
Cell Subsets |
RA (% cell ± SD) |
Control (% cell ± SD) |
p value |
|
|
|||
|
CD4+ CD25+ |
4,9 ± 2,9 |
3,1 ± 2,0 |
0,001 |
|
|
|||
|
CD4+ CD25+ FoxP3+ |
0,8 ± 1,9 |
0,6 ± 0,4 |
0,259 |
|
|
|||
|
Bisgin et al. BMC Musculoskeletal Disorders 2010 11:192 doi:10.1186/1471-2474-11-192 |
|||
